Page last updated: 2024-08-21

pyrazines and Cardiac Cancer

pyrazines has been researched along with Cardiac Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bačovský, J; Látalová, P; Lochman, P; Metelka, R; Minařík, J; Pika, T; Ščudla, V; Vymětal, J; Zapletalová, J1
Ewald, GA; Hassan, A; Joseph, SM; Klein, JL; Uy, GL; Wang, TF; Woodard, PK1

Other Studies

2 other study(ies) available for pyrazines and Cardiac Cancer

ArticleYear
[Attainment of complete hematological remission is crucial for extended survival of AL amyloidosis patients with cardiac involvement].
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2013, Volume: 26, Issue:5

    Topics: Aged; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Female; Heart Neoplasms; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Pyrazines; Remission Induction; Thalidomide; Treatment Outcome

2013
Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literature.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Sep-20, Volume: 30, Issue:27

    Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Heart Neoplasms; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphoproliferative Disorders; Plasmacytoma; Pyrazines

2012